Evidence map›Paper›PMID 15561883›Full record

ArticleAntimicrobial agents and chemotherapy2004

In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus isolates from transplant and nontransplant patients.

William J Steinbach, Nina Singh, Jackie L Miller, Daniel K Benjamin, Wiley A Schell, Joseph Heitman, John R Perfect

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Potential Antifungal Targets forInternational journal of molecular sciences · 2022
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

William J SteinbachDivision of Pediatric Infectious Diseases, Department of Pediatrics, Duke University Medical Center, Durham, North Carolina 27710, USA. stein022@mc.duke.edu
Nina Singh
Jackie L Miller
Daniel K Benjamin
Wiley A Schell
Joseph Heitman
John R Perfect
Office of Infectious Diseases · USClinical Research Institute · USDuke University Hospital · USUniversity of Pittsburgh Medical Center · US

Funding

Pediatric Scientist Development Program (PSDP) [K12]K12HD000850 · NICHD · YALE UNIVERSITY · PI Sallie R. Permar · 1987 to 2026
$44.1M
Novel Antifungal Therapeutic ApproachesR01AI050438 · NIAID · DUKE UNIVERSITY · PI HEITMAN, JOSEPH · 2001 to 2012
$3.3M
GENTIC &MOLECULAR BIOLOGY OF VIRULENCE IN C. NEOFORMANSR01AI028388 · NIAID · DUKE UNIVERSITY · PI PERFECT, JOHN R. · 1991 to 2004
$1.9M
C. Neoformans Infection in Organ Transplant RecipientsR01AI054719 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SINGH, NINA · 2003 to 2005
$781k
Genetic molecular biology of virulence in C. neoformansR56AI028388 · NIAID · DUKE UNIVERSITY · PI PERFECT, JOHN R. · 2006 to 2006
$389k
Clinical Predictors of Antiretroviral FailureR03HD042940 · NICHD · DUKE UNIVERSITY · PI BENJAMIN, DANIEL K · 2002 to 2003
$154k
NIAID NIH HHS 1 R01 AI054719-01NIAID NIH HHS AI-28388NIAID NIH HHS AI-50438NIAID NIH HHS P01-AI-449175NIAID NIH HHS R01 AI028388NIAID NIH HHS R01 AI050438NIAID NIH HHS R01 AI054719NIAID NIH HHS R56 AI028388NICHD NIH HHS 1 R03 HD42940-02NICHD NIH HHS K12 HD000850NICHD NIH HHS K12-HD00850NICHD NIH HHS R03 HD042940
6 · The paper itself

Abstract

We performed in vitro antifungal checkerboard testing on 12 Aspergillus fumigatus clinical isolates (6 transplant recipients and 6 nontransplant patients) with three antifungal agents (amphotericin B, voriconazole, and caspofungin) and three immunosuppressants (FK506, cyclosporine, and rapamycin). We were not able to detect a difference in calcineurin inhibitor antifungal activity against isolates from transplant recipients and nontransplant patients.

Indexed as

Organ TransplantationAmphotericin BAntifungal AgentsAspergillosisAspergillus fumigatusCalcineurin InhibitorsCaspofunginCyclosporineEchinocandinsHumansImmunosuppressive AgentsLipopeptidesPeptides, CyclicPyrimidinesTacrolimusTriazolesAmphotericin BAntifungal AgentsCalcineurin InhibitorsCaspofunginCyclosporineEchinocandinsImmunosuppressive AgentsLipopeptidesPeptides, CyclicPyrimidinesTacrolimusTriazolesVoriconazole

Identifiers

PMID15561883
PMCPMC529228
OpenAlexW2027782516

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.